Dan Sheridan Talks Covid Vaccine Stocks

Dan Sheridan on Johnson & Johnson (JNJ) saying that a single-dose Covid-19 vaccine is 66% effective in moderate-to-severe cases. Also, Eli Lilly (LLY) reported earnings of $2.75 EPS with a $7.44B in revenue.

MID-DAY Movers

29 Jan 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

Dan Sheridan Talks Covid Vaccine Stocks

Dan Sheridan on Johnson & Johnson (JNJ) saying that a single-dose Covid-19 vaccine is 66% effective in moderate-to-severe cases. Also, Eli Lilly (LLY) reported earnings of $2.75 EPS with a $7.44B in revenue.

MID-DAY Movers

29 Jan 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US